CD83 is a regulator of murine B cell function in vivo (Q38920553)

7 September 2017

CD83 is a regulator of murine B cell function in vivo (English)

1 reference

7 September 2017

Simon Fillatreau

8

0 references

Minka Breloer

object named as

Minka Breloer

1

0 references

Christiane Steeg

7

object named as

Christiane Steeg

1 reference

7 September 2017

3

Katja Lüthje

1 reference

7 September 2017

4

Svenja Ehrlich

1 reference

7 September 2017

Birte Kretschmer

2

1 reference

7 September 2017

Uwe Ritter

5

1 reference

7 September 2017

Thomas Bickert

6

1 reference

7 September 2017

Kai Hoehlig

9

1 reference

7 September 2017

Vassiliki Lampropoulou

10

1 reference

7 September 2017

Bernhard Fleischer

11

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 March 2007

1 reference

European Journal of Immunology

7 September 2017

1 reference

7 September 2017

37

1 reference

7 September 2017

3

1 reference

7 September 2017

634-648

1 reference

A novel mutation in CD83 results in the development of a unique population of CD4+ T cells

7 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

Cutting edge: CD83 regulates the development of cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

The mouse Cd83 gene: structure, domain organization, and chromosome localization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Expression of CD83 in the murine immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

CD83 expression influences CD4+ T cell development in the thymus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

CD83 on dendritic cells: more than just a marker for maturation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Melanoma cells transfected to express CD83 induce antitumor immunity that can be increased by also engaging CD137.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Enhanced activation of CD83-positive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

The immunology of susceptibility and resistance to Leishmania major in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

T helper (h)1/Th2 and Leishmania: paradox rather than paradigm

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

T cell-independent antigens type 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Polarized helper-T-cell responses against Leishmania major in the absence of B cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Cell-mediated immunity in experimental Trypanosoma cruzi infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Control of B-cell responses by Toll-like receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Immunology: Toll-like receptors and antibody responses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Regulation of B-cell fate by antigen-receptor signals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

CD22 is a negative regulator of B-cell receptor signalling

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Siglecs in the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

The control of Leishmania (Leishmania) major by TNF in vivo is dependent on the parasite strain.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200636852

7 January 2021

Identifiers

DOI

10.1002/EJI.200636852

1 reference

7 September 2017

1 reference